News & Updates
Filter by Specialty:
RT may be omitted after breast-conserving surgery in T1N0, grade 1/2, luminal A breast cancer
Radiotherapy (RT) may be omitted in women ≥55 years of age with T1N0, grade 1 or 2, luminal A breast cancer who have been treated with breast-conserving surgery and endocrine therapy, due to the very low risk of 5-year local recurrence reported in a recent prospective cohort study.
RT may be omitted after breast-conserving surgery in T1N0, grade 1/2, luminal A breast cancer
04 Sep 2023
Do weak opioids increase risk of GI cancers?
Evidence on the association of weak opioids with a higher risk of oesophageal and colorectal cancer is not reliable, but there appears to be a small association with gastric cancer, suggests a study.
Do weak opioids increase risk of GI cancers?
30 Aug 2023
Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis
Novel systemic treatments are similarly effective in reducing the risk of progression or death in patients with metastatic hormone-sensitive (mHSPC) and castration-resistant prostate cancer (mCRPC), irrespective of visceral metastasis status, reports a study.
Novel systemic therapies improve survival in prostate cancer patients with visceral metastasis
30 Aug 2023
Working out heightens sexual function in men with prostate cancer
Prostate cancer treatment upends sexual function in men, but the good news is that supervised resistance and aerobic workout can counter these sexual side effects, according to a study presented at ASCO Breakthrough 2023.
